Cellular pharmacology studies of shikonin derivatives

Phytotherapy Research - Tập 16 Số 3 - Trang 199-209 - 2002
Xin Chen1, Lu Yang1, Joost J. Oppenheim1, O. M. Zack Howard1
1Laboratory of Molecular Immunoregulation, Division of Basic Sciences, National Cancer Institute-Frederick, Frederick, MD 21702-1201, USA

Tóm tắt

Abstract

The naphthoquinone pigment, shikonin, isolated from Lithospermum erythrorhizon Sieb. et Zucc.(Boraginaceae) and its derivatives are the active components isolated from the Chinese herbal therapeutic, Zicao. Historically, Zicao root extracts have been used to treat macular eruption, measles, sore‐throat, carbuncles and burns. Multiple pharmacological actions have been attributed to shikonin, e.g. antiinflammatory, antigonadotropic and anti‐HIV‐1 activity. In this review, several therapeutic applications of shikonin will be summarized including its pleiotropic, antiinflammatory and antitumour effects. Widely diverse and sometimes conflicting activities have been attributed to shikonin, e.g. wound healing, enhanced granuloma formation, suppression of local acute inflammatory reactions, inhibition of angiogenesis, inhibition of select chemokine ligands, inhibition of DNA topoisomerase activity, inhibition of platelet activation and antimicrobial activity. Comparison of the various reported mechanisms of action for shikonin lead us to hypothesize that shikonin is an effective inhibitor of protein–protein interaction with multiple targets in both the intracellular and extracellular compartments. This general inhibitory effect can account for the broad spectrum of shikonin biological and pharmacological activities. Published in 2002 by John Wiley & Sons, Ltd.

Từ khóa


Tài liệu tham khảo

10.1021/jm00006a025

10.1016/0163-7258(91)90034-J

10.1055/s-2007-1014739

10.1038/33340

10.2174/0929867003375489

Bhalla K, 1993, Taxol induces internucleosomal DNA fragmentation associated with programmed cell death in human myeloid leukemia cells, Leukemia, 7, 563

10.1104/pp.119.2.417

10.1126/science.279.5350.563

10.1055/s-2006-959718

10.1016/S1567-5769(00)00033-3

10.1016/0010-7824(81)90101-3

10.1016/0010-7824(80)90132-8

10.1038/339058a0

Fu SL, 1984, Analysis of naphthaquinone pigments in Chinese medicinal ‘zicao’, Arnebia euchroma, Yao Xue Xue Bao, 19, 921

10.1128/AAC.36.12.2589

Gaddipati JP, 2000, Inhibition of growth and regulation of IGFs and VEGF in human prostate cancer cell lines by shikonin analogue 93/637 (SA), Anticancer Res, 20, 2547

10.1016/S0968-0896(00)00191-7

Grimberg A RR, 1998, The Prostatic IGF System: New Levels of Complexity

Guo XP, 1991, Clinical trial on the effects of shikonin mixture on later stage lung cancer, Zhong Xi Yi Jie He Za Zhi, 11, 598

Gupta SK, 1972, The effect of Arnebia nobilis and its naphthaquinones in rat Walker carcinosarcoma 256, Indian J Cancer, 9, 50

10.1093/oxfordjournals.jbchem.a022255

10.1254/fpj.73.205

10.1254/fpj.73.193

Hisa T, 1998, Shikonin, an ingredient of Lithospermum erythrorhizon, inhibits angiogenesis in vivo and in vitro, Anticancer Res, 18, 783

10.1021/np50055a025

10.1016/0165-6147(94)90077-9

Jian Y, 1991, Quality of Chinese drug zicao, Zhongg Zhong Yao Za Zhi, 16, 524

Jiansu Xin Yi Xue Yuan, 1977, Chinese Materia Medica Dictionary

10.1016/S0378-8741(96)01477-8

10.1016/S0304-3835(96)04582-X

Katti SB, 1979, Arnebin derivatives for anticancer activity, Indian J Chem, 18, 440

Kaufmann SH, 1989, Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note, Cancer Res, 49, 5870

10.1248/bpb.19.1266

10.1016/S0304-3835(01)00665-6

10.1016/0167-4889(95)00078-7

10.1021/np50065a012

10.1016/0165-1218(88)90093-6

10.1002/(SICI)1099-1573(199905)13:3<236::AID-PTR417>3.0.CO;2-F

Lu G, 1990, Detection of the anti‐cancer biological effect of naphthoquinone pigment‐LIII, Zhong Xi Yi Jie He Za Zhi, 10, 422

Luo SR, 1991, Determination of naphthoquinones in tissue cultured Zicao, Yao Xue Xue Bao, 26, 953

Luo S, 1992, Determination of naphthoquinone in zicao, Zhongg Zhong Yao Za Zhi, 17, 552

10.1248/bpb.16.683

10.1248/bpb.17.1075

10.1248/bpb.21.366

10.1002/(SICI)1521-3773(19990201)38:3<270::AID-ANIE270>3.0.CO;2-0

10.1016/S0960-894X(98)00600-3

10.1248/bpb.24.650

10.1248/cpb.25.2392

10.1248/cpb.29.116

10.1248/yakushi1947.120.6_587

10.1248/bpb.21.950

Seto Y, 1992, Effect of shikonin and its derivatives, pentaacetylated shikonin (MDS‐004) on granuloma formation and delayed‐type allergy in experimental animals, Yakugaku Zasshi, 112, 259, 10.1248/yakushi1947.112.4_259

10.1007/BF01899915

10.1046/j.1523-1747.1999.00761.x

10.1055/s-2007-971251

10.1177/108705710100600206

10.1248/yakushi1947.95.11_1376

10.1021/np50045a014

Ueba N, 1993, Anti‐HIV‐1 activities of crude drug, shikon (Lithospermi radix), in vitro, Nippon Rinsho, 51, 207

10.1146/annurev.bi.54.070185.003313

Wang JC, 1987, DNA topoisomerases: from a laboratory curiosity to a subject in cancer chemotherapy, NCI Monogr, 4, 3

10.1016/S0006-2952(97)00098-1

10.1016/0014-2999(94)00627-J

10.1038/sj.bjp.0701147

Wang WJ, 1994, The antiinflammatory activity of shikonin and its inhibitory effect on leukotriene B4 biosynthesis, Yao Xue Xue Bao, 29, 161

Wang WJ, 1988, A study on absorption, distribution and excretion of 3H‐shikonin in mice, Yao Xue Xue Bao, 23, 246

10.1055/s-2006-962360

10.1055/s-2007-1018769

Withoff S, 1996, Human DNA topoisomerase II: biochemistry and role in chemotherapy resistance, Anticancer Res, 16, 1867

10.1248/yakushi1947.113.11_818

10.1055/s-1999-14010

10.1111/j.1349-7006.1992.tb02758.x

Thông tin
Thông tin xuất bản

Phytotherapy Research

Tập 16 Số 3

199-209

Thông tin tác giả